Patents by Inventor Jeffrey Musselman

Jeffrey Musselman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
    Patent number: 7763659
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: July 27, 2010
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell, Jeffrey Musselman, James J. Perkins, Jiabing Wang
  • -(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
    Patent number: 7629367
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: December 8, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell, Jeffrey Musselman, James J. Perkins, Jiabing Wang
  • N-(2-Benzyl)-2-Phenylbutanamides As Androgen Receptor Modulators
    Publication number: 20080139630
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Application
    Filed: June 3, 2005
    Publication date: June 12, 2008
    Inventors: Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell, Jeffrey Musselman, James J. Perkins, Jiabing Wang
  • N-(Pyridin-3-Yl)-2-Phenylbutanamides As Androgen Receptor Modulators
    Publication number: 20080124402
    Abstract: Compounds of structural formula (I) are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Application
    Filed: October 25, 2005
    Publication date: May 29, 2008
    Applicant: MERCK & CO., INC.
    Inventors: Yuntae Kim, Joshua Close, Mark E. Duggan, Barbara Hanney, Robert S. Meissner, Jeffrey Musselman, James J. Perkins, Jiabing Wang
  • N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
    Publication number: 20070225229
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Application
    Filed: March 1, 2007
    Publication date: September 27, 2007
    Inventors: Barbara Hanney, Yuntae Kim, Michael Krout, Robert Meissner, Helen Mitchell, Jeffrey Musselman, James Perkins, Jiabing Wang
  • N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
    Patent number: 7268153
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: September 11, 2007
    Assignee: Merck & Co., Inc.
    Inventors: Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell, Jeffrey Musselman, James J. Perkins, Jiabing Wang
  • N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
    Publication number: 20050277681
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Application
    Filed: June 3, 2005
    Publication date: December 15, 2005
    Inventors: Barbara Hanney, Yuntae Kim, Michael Krout, Robert Meissner, Helen Mitchell, Jeffrey Musselman, James Perkins, Jiabing Wang